KAITLYN KEMPF: Open Payments
NPI 1760947907 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 69 payments from 16 companies in 2025. Trend: 2023 $1,144 · 2024 $1,824 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $266 |
| Lilly USA, LLC | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| GlaxoSmithKline, LLC. | 4 | $100 |
| PFIZER INC. | 5 | $96 |
| Radius Health, Inc. | 4 | $91 |
| Amgen Inc. | 5 | $88 |
| Astellas Pharma US Inc | 3 | $81 |
| Novo Nordisk Inc | 4 | $75 |
| Antares Pharma, Inc. | 2 | $51 |
Products named: UBRELVY, VRAYLAR, Tymlos, EVENITY, MOUNJARO, Veozah, KISUNLA, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
